2018
DOI: 10.1016/j.pharmthera.2018.06.004
|View full text |Cite
|
Sign up to set email alerts
|

Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management

Abstract: Although advances in medical technology and health care have improved the early diagnosis and management for cardiorenal metabolic disorders, the prevalence of obesity, insulin resistance, diabetes, hypertension, dyslipidemia, and kidney disease remains high. Findings from numerous population-based studies, clinical trials, and experimental evidence have consolidated a number of theories for the pathogenesis of cardiorenal metabolic anomalies including resistance to the metabolic action of insulin, abnormal gl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
73
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 91 publications
(74 citation statements)
references
References 333 publications
1
73
0
Order By: Relevance
“…Several factors are involved in the progression of IR induced by HFD including inflammation, excessive ROS, abnormal immune response, lipotoxicity and altered glycosylation . Recently, an important role for protein quality control, particularly autophagy, has been depicted in the maintenance of metabolic homeostasis . However, the mechanism underlying IR is far from clarified.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Several factors are involved in the progression of IR induced by HFD including inflammation, excessive ROS, abnormal immune response, lipotoxicity and altered glycosylation . Recently, an important role for protein quality control, particularly autophagy, has been depicted in the maintenance of metabolic homeostasis . However, the mechanism underlying IR is far from clarified.…”
Section: Discussionmentioning
confidence: 99%
“…1,[24][25][26][27][28] Recently, an important role for protein quality control, particularly autophagy, has been depicted in the maintenance of metabolic homeostasis. 29 However, the mechanism underlying IR is far from clarified. Our data showed that the lipogenesis, lipid accumulation, lipid oxidation and gluconeogenesis in liver was inhanced induced by HFD, while the glycolysis was suppressed.…”
Section: Discussionmentioning
confidence: 99%
“…Mice with podocyte-specific deletion of autophagic regulators, such as class III PI3K vacuolar protein sorting 34 (Vps34) and the Atg5 gene, develop early proteinuria, progressive glomerulosclerosis, and renal failure [6]. Accordingly, autophagy is considered a potential therapeutic target for renal protection [8,9].Sodium-glucose cotransporter-2 (SGLT2) inhibitors and dipeptidylpeptidase-4 (DPP4) inhibitors are promising antidiabetic agents introduced into clinical practice in the last decade. The antihyperglycemic effect of SGLT2 inhibitors is mediated by increment of glucosuria, while DPP4 inhibitors realize their activity through an increase in the half-life of incretin hormones.…”
mentioning
confidence: 99%
“…Mice with podocyte-specific deletion of autophagic regulators, such as class III PI3K vacuolar protein sorting 34 (Vps34) and the Atg5 gene, develop early proteinuria, progressive glomerulosclerosis, and renal failure [6]. Accordingly, autophagy is considered a potential therapeutic target for renal protection [8,9].…”
mentioning
confidence: 99%
“…Cellular ROS are commonly generated through mitochondrial respiratory chain in most tissues. Steady-state ROS are maintained at nontoxic levels through various antioxidant and repair enzymes [2,5,6]. The delicate balance between oxidative stress and antioxidant defenses appears to play an essential role in cell survival, proliferation, and cell death [7,8].…”
Section: Introductionmentioning
confidence: 99%